Jason Coloma V
Chief Executive Officer at Maze Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 2 boards, counting each seat separately. Longest: Maze Therapeutics Inc., 1 year.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Maze Therapeutics Inc. June 8, 202685.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Maze Therapeutics Inc. | Open-market sale | −2,257 | $30.12 | $67,990 |
| Nov 2, 2026 | Maze Therapeutics Inc. | Open-market sale | −336 | $30.91 | $10,385 |
| Nov 2, 2026 | Maze Therapeutics Inc. | Open-market sale | −26,563 | $30.10 | $799,413 |
| Nov 2, 2026 | Maze Therapeutics Inc. | Open-market sale | −5,345 | $31.05 | $165,977 |
| Oct 1, 2026 | Maze Therapeutics Inc. | Open-market sale | −2,593 | $27.02 | $70,073 |
| Oct 1, 2026 | Maze Therapeutics Inc. | Open-market sale | −31,908 | $27.02 | $862,186 |
| Sep 3, 2026 | Maze Therapeutics Inc. | Open-market sale | −11,282 | $26.01 | $293,445 |
| Sep 3, 2026 | Maze Therapeutics Inc. | Open-market sale | −129 | $25.77 | $3,324 |
| Sep 2, 2026 | Maze Therapeutics Inc. | Open-market sale | −9,852 | $26.38 | $259,896 |
| Sep 2, 2026 | Maze Therapeutics Inc. | Open-market sale | −1,375 | $27.12 | $37,290 |
| Sep 1, 2026 | Maze Therapeutics Inc. | Open-market sale | −2,593 | $26.31 | $68,222 |
| Sep 1, 2026 | Maze Therapeutics Inc. | Open-market sale | −31,908 | $26.29 | $838,861 |
| Sep 1, 2026 | Maze Therapeutics Inc. | Option exercise | +50,000 | — | — |
| Aug 3, 2026 | Maze Therapeutics Inc. | Open-market sale | −2,439 | $26.71 | $65,146 |
| Aug 3, 2026 | Maze Therapeutics Inc. | Open-market sale | −154 | $27.09 | $4,172 |
Questions about Jason Coloma V
What boards is Jason Coloma V on?
Jason Coloma V sits on the boards of Braveheart Bio Inc. and Maze Therapeutics Inc.
What company is Jason Coloma V the CEO of?
Jason Coloma V has been Chief Executive Officer of Maze Therapeutics Inc. since January 2025.
How long has Jason Coloma V served on boards?
Our records show at least 2 years of board service across 2 boards, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.